» Articles » PMID: 21854633

Kbus/Idr, a Mutant Mouse Strain with Skeletal Abnormalities and Hypophosphatemia: Identification As an Allele of 'Hyp'

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2011 Aug 23
PMID 21854633
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The endopeptidase encoded by Phex (phosphate-regulating gene with homologies to endopeptidases linked to the X chromosome) is critical for regulation of bone matrix mineralization and phosphate homeostasis. PHEX has been identified from analyses of human X-linked hypophosphatemic rickets and Hyp mutant mouse models. We here demonstrated a newly established dwarfism-like Kbus/Idr mouse line to be a novel Hyp model.

Methods: Histopathological and X-ray examination with cross experiments were performed to characterize Kbus/Idr. RT-PCR-based and exon-directed PCR screening performed to identify the presence of genetic alteration. Biochemical assays were also performed to evaluate activity of alkaline phosphatase.

Results: Kbus/Idr, characterized by bone mineralization defects, was found to be inherited in an X chromosome-linked dominant manner. RT-PCR experiments showed that a novel mutation spanning exon 16 and 18 causing hypophosphatemic rickets. Alkaline phosphatase activity, as an osteoblast marker, demonstrated raised levels in the bone marrow of Kbus/Idr independent of the age.

Conclusions: Kbus mice should serve as a useful research tool exploring molecular mechanisms underlying aberrant Phex-associated pathophysiological phenomena.

Citing Articles

PHEX Mutation Increases Expression in a New ENU Mouse Model for XLH Disease.

El Hakam C, Parente A, Baraige F, Magnol L, Forestier L, Di Meo F Genes (Basel). 2022; 13(8).

PMID: 36011266 PMC: 9407253. DOI: 10.3390/genes13081356.


New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis.

Sabrautzki S, Rubio-Aliaga I, Hans W, Fuchs H, Rathkolb B, Calzada-Wack J Mamm Genome. 2012; 23(7-8):416-30.

PMID: 22527485 PMC: 3401305. DOI: 10.1007/s00335-012-9397-z.

References
1.
Ruppe M, Brosnan P, Au K, Tran P, Dominguez B, Northrup H . Mutational analysis of PHEX, FGF23 and DMP1 in a cohort of patients with hypophosphatemic rickets. Clin Endocrinol (Oxf). 2010; 74(3):312-8. PMC: 3035757. DOI: 10.1111/j.1365-2265.2010.03919.x. View

2.
Holm I, Nelson A, Robinson B, Mason R, Marsh D, Cowell C . Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 2001; 86(8):3889-99. DOI: 10.1210/jcem.86.8.7761. View

3.
Nakatani T, Ohnishi M, Razzaque M . Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J. 2009; 23(11):3702-11. PMC: 2775000. DOI: 10.1096/fj.08-123992. View

4.
Wang X, Levic S, Gratton M, Doyle K, Yamoah E, Pegg A . Spermine synthase deficiency leads to deafness and a profound sensitivity to alpha-difluoromethylornithine. J Biol Chem. 2008; 284(2):930-7. PMC: 2613633. DOI: 10.1074/jbc.M807758200. View

5.
Ichikawa S, Traxler E, Estwick S, Curry L, Johnson M, Sorenson A . Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets. Bone. 2008; 43(4):663-6. PMC: 2579265. DOI: 10.1016/j.bone.2008.06.002. View